HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence and big data.
HeraMED is led by a team of medical professionals, engineers, product developers, marketing experts and parents.
HeraBEAT, our FDA Cleared and CE Certified fetal heart-rate monitor, allows expecting parents to measure their baby's heartbeats from the comfort of home.
HeraCARE is our end-to-end remote monitoring platform, which allows providers to design and manage care plans from afar with connected devices, educational content, symptom and sentiment tracking, and more.
Technology has the power to optimize, improve, and dramatically change prenatal care.
Our goal at HeraMED is to use our tech and our human hearts to power the best possible pregnancy experiences the world round.
Overview
FAQ about HeraMED Limited
When was HeraMED Limited founded?
HeraMED Limited was founded in 2011.
Is HeraMED Limited still active?
Yes, HeraMED Limited is active; its latest activity on Parsers VC dates from Apr 7, 2022.